Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 2Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1Phase 1 1

Status

Recruiting 3Unknown 2Not yet recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Anus Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Probiotics × Clear all
NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown
75 enrolled
Gastrointestinal

Anus Neoplasms

NCT00319007 2007-08-10

Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis

Radboud University Medical Center

Phase 2 Unknown
30 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡